Author

Vaughn Thada

Observed name: V. Thada

Institution: Integrated DNA Technologies (United States)

Observed institutions: Augustana University, Vanderbilt University, Sanford Research, Integrated DNA Technologies (United States), University of Pennsylvania, Vanderbilt University Medical Center

ORCID: 0000-0002-9245-4354

Observed ORCID: 0000-0002-9245-4354

OpenAlex ID: A5059270480

CHK1 phosphorylates PRIMPOL to promote replication stress tolerance

2022 · Kavi P. M. Mehta, Vaughn Thada, et al. · Science Advances · 70

Common motifs in ETAA1 and TOPBP1 required for ATR kinase activation

2019 · Vaughn Thada, David Cortez · Journal of Biological Chemistry · 41

Tissue‐specific variation in nonsense mutant transcript level and drug‐induced read‐through efficiency in the Cln1R151X mouse model of INCL

2015 · Vaughn Thada, Jake N. Miller, et al. · Journal of Cellular and Molecular Medicine · 29

ATR activation is regulated by dimerization of ATR activating proteins

2021 · Vaughn Thada, David Cortez · Journal of Biological Chemistry · 24

Autologous K63 deubiquitylation within the BRCA1-A complex licenses DNA damage recognition

2022 · Qinqin Jiang, Martina Foglizzo, et al. · The Journal of Cell Biology · 18

Unpaved roads: How the DNA damage response navigates endogenous genotoxins

2022 · Vaughn Thada, Roger A. Greenberg · DNA repair · 14

Lipid Nanoparticle-Mediated Gene Editing of Human Primary T Cells and Off-Target Analysis of the CRISPR-Cas9 Indels

2023 · Reka Geczy, Bernice Thommandru, et al. · Blood · 7

Optimization of Multiplex Crispr-cas9 Editing of Human Primary T Cells Using Lipid Nanoparticles (lnps) and Subsequent Off-target Evaluation

2024 · M. Swaminathan, B.C. Thommandru, et al. · Cytotherapy

Gene Editing/Gene Therapies: NON-VIRAL LIPID NANOPARTICLE-MEDIATED GENE EDITING OF HUMAN PRIMARY T CELLS AND OFF-TARGET ANALYSIS OF THE CRISPR-CAS9 INDELS

2023 · R. Geczy, B. Thommandru, et al. · Cytotherapy

Works count: 9

Citation count: 203

H-index: 7

I10-index: 6